News

Moderna Is More Than Its Covid Vaccine. Why It’s Time to Buy the Stock.

Moderna, a drugmaker with just a single product to its name, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.

Yet investors don’t seem to know what to make of it anymore, and the stock is stuck in a spin cycle.

In the first…

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News